Literature DB >> 20167400

[Hypercalcemia-hyperleukocytosis paraneoplastic syndrome complicating cutaneous squamous cell carcinoma. Report of two cases].

B Ben Said1, S Maitre, J-L Perrot, B Labeille, F Cambazard.   

Abstract

INTRODUCTION: We report two cases of hypercalcemia-hyperleucocytosis paraneoplastic syndrome complicating cutaneous squamous cell carcinoma. CASE REPORTS: The first patient, a 50-year-old man, suffering for hidradenitis suppurativa for the past 20 years, was admitted for squamous cell carcinoma. Laboratory findings showed marked hypercalcemia and hyperleucocytosis. PTHrP serum level was increased. Bone scintigraphy was normal. There was evidence of pulmonary metastasis. Despite treatment the patient died of agranulocytosis. The second patient was a 60-year-old man who presented with several months enlarging left axillary tumour. He has been treated by surgery for a squamous cell carcinoma of the left hand, 6 months ago. Serum calcium and white cell bloods count were elevated. The diagnosis of metastatic lymph node of cutaneous squamous cell carcinoma was confirmed. There was evidence of pulmonary metastasis. Despite chemotherapy the patient died rapidly.
CONCLUSION: Hypercalcemia-hyperleucocytosis paraneoplastic syndrome is rarely described during the course of cutaneous squamous cell carcinoma. This syndrome seems to be related to hormones or cytokines secretion by the neoplasic cells including PTHrP and G-CSF. Some authors ascribe it a poor prognostic significance. Copyright 2010. Published by Elsevier SAS.

Entities:  

Mesh:

Year:  2010        PMID: 20167400     DOI: 10.1016/j.revmed.2009.08.004

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Successful treatment of paraneoplastic hypercalcemia in a patient with giant condyloma acuminatum: a case report.

Authors:  Thomas Linnemann; Frauke Müller; Mathias Löhnert; Peter Hirnle; Martin Görner
Journal:  J Med Case Rep       Date:  2013-11-07

Review 2.  Paraneoplastic Syndromes in Patients with Keratinocyte Skin Cancer.

Authors:  Christoforos Vlachos; Chrysanthi Tziortzioti; Ioannis D Bassukas
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

3.  Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy.

Authors:  Thilo Gambichler; E Stockfleth; L Susok
Journal:  J Immunother Cancer       Date:  2018-10-30       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.